Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
20.60
+0.60 (3.00%)
At close: Oct 15, 2026, 4:00 PM EDT
20.19
-0.41 (-1.99%)
After-hours: Oct 15, 2026, 5:29 PM EDT
Faeth Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Faeth Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $56.67. The average 1-year stock price forecast is 175.10% higher than the current stock price, while the lowest is $46 (+123.30%) and the highest is $70 (+239.81%).
Price Target: $56.67 (+175.10%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Faeth Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 7 | 8 | 9 | 11 | 11 |
| Buy | 0 | 0 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 7 | 10 | 12 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Initiates $40 | Buy | Initiates | $40 | +94.17% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $60 | Buy | Maintains | $60 | +191.26% | Sep 22, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $70 | Buy | Initiates | $70 | +239.81% | Sep 15, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $59 | Buy | Initiates | $59 | +186.41% | Sep 14, 2026 |
| BTIG | BTIG | Buy Maintains $55 | Buy | Maintains | $55 | +166.99% | Sep 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-13.78
EPS Next Year
-4.49
from -13.78
EPS and Forward PE are based on non-GAAP adjusted numbers.